ABBV (STOCKS)
ABBVIE INC.
$250.500000
+1.740000 (+0.70%)
Prev close: $248.760000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert A. Michael
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $449,829.01M
- Employees
- 55,000
- P/E (TTM)
- 70.33
- P/B (TTM)
- -74.07
- Dividend Yield
- 274.56%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $64.39B |
| Benefits Costs and Expenses | $41.74B |
| Cost Of Revenue | $18.37B |
| Costs And Expenses | $35.44B |
| Gross Profit | $46.02B |
| Operating Expenses | $29.15B |
| Selling, General, and Administrative Expenses | $14.67B |
| Other Operating Expenses | $14.48B |
| Operating Income/Loss | $16.87B |
| Income/Loss From Continuing Operations After Tax | $6.32B |
| Income/Loss From Continuing Operations Before Tax | $22.65B |
| Income Tax Expense/Benefit | $2.38B |
| Income Tax Expense/Benefit, Deferred | -$250.00M |
| Interest Expense, Operating | $2.92B |
| Net Income/Loss | $6.32B |
| Net Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Net Income/Loss Attributable To Parent | $6.31B |
| Net Income/Loss Available To Common Stockholders, Basic | $6.28B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $30.00M |
| Preferred Stock Dividends And Other Adjustments | $30.00M |
| Basic Earnings Per Share | $3.54 |
| Diluted Earnings Per Share | $3.54 |
| Basic Average Shares | 3,538,000,000 |
| Diluted Average Shares | 3,546,000,000 |
| Assets | $135.12B |
| Current Assets | $33.67B |
| Inventory | $5.13B |
| Other Current Assets | $28.54B |
| Noncurrent Assets | $101.45B |
| Fixed Assets | $5.80B |
| Intangible Assets | $49.14B |
| Other Non-current Assets | $46.51B |
| Liabilities | $141.00B |
| Current Liabilities | $41.64B |
| Noncurrent Liabilities | $99.36B |
| Equity | -$5.89B |
| Equity Attributable To Noncontrolling Interest | $47.00M |
| Equity Attributable To Parent | -$5.94B |
| Liabilities And Equity | $135.12B |
| Net Cash Flow From Operating Activities | $19.51B |
| Net Cash Flow From Operating Activities, Continuing | $19.51B |
| Net Cash Flow From Investing Activities | -$6.50B |
| Net Cash Flow From Investing Activities, Continuing | -$6.50B |
| Net Cash Flow From Financing Activities | -$12.89B |
| Net Cash Flow From Financing Activities, Continuing | -$12.89B |
| Exchange Gains/Losses | -$16.00M |
| Net Cash Flow | $102.00M |
| Net Cash Flow, Continuing | $118.00M |
| Comprehensive Income/Loss | $6.27B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Comprehensive Income/Loss Attributable To Parent | $6.26B |
| Other Comprehensive Income/Loss | -$50.00M |